MDM2 is considered to be the main negative regulator of p53, the tumor suppressor gene most frequently mutated in human cancers, preventing nuclear translocation and transcription and promoting its degradation by E3 ubiquitin ligase. This evidence concerns the gene MDM2 and cancer.